Position in TRDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,280,284
-$3,141,634 QoQ
Shares Held
717,430
+7.5% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. TRDA ranks #232 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,280,284 | 717,430 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $8,421,918 | 667,347 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,578,654 | 639,947 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,741,689 | 645,119 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,244,042 | 631,554 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,325,237 | 589,075 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,922,574 | 573,891 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,211,686 | 576,451 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,551,630 | 529,939 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $6,735,822 | 475,358 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,932,059 | 459,381 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,929,579 | 438,581 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,065,553 | 400,631 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,664,955 | 183,790 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,460,058 | 181,957 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,633,779 | 167,118 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,239,570 | 101,771 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,668,912 | 177,733 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,776,641 | 162,187 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||